Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Piramal Pharma has informed that it enclosed the Postal Ballot Notice dated 8th February, 2023 (‘Postal Ballot Notice’) along with the explanatory statement seeking approval of the Members of the Company on the Resolutions set out in the Postal Ballot Notice. In accordance with the circulars issued by the Ministry of Corporate Affairs, from time to time, the Postal Ballot Notice is being sent only through electronic mode to those Members of the Company whose e-mail addresses are registered with the Company/ Depositories and whose names appear in the Register of Members/ List of Beneficial Owners as on the cut-off date Friday, 10th February, 2023. Accordingly, the physical copy of the Postal Ballot Notice along with postal ballot form and pre- paid business reply envelope is not being sent to the Members for this Postal Ballot. The Company has engaged the services of National Securities Depository (‘NSDL’), for providing remote e-voting facility to the Members. The remote e-voting will commence on Sunday, 19th February, 2023 at 9:00 am (IST) and ends on Monday, 20th March, 2023 at 5:00 pm (IST). The Postal Ballot Notice is also being made available on the website.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |